In summary, the core IRGs involve tumor-related pathways including the phosphoinositide 3-kinase (PI3K)/AKT, NF-κB, Notch, Wnt, JAK/STAT, TGF-β/Smad, PKC, and RAS/MAPK pathways. The gene discussed is PRRT2; the disease is neoplasm.